Biotechnology News

May 7, 2012

CARLSBAD, Calif. & SUZHOU, China--(BUSINESS WIRE)--The international biotech and pharma community will converge upon the city of Suzhou, China, a rapidly growing base for life science industries, at ChinaBio® Partnering Forum 2012 on May 23...

May 7, 2012

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for...

May 7, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., today announced an agreement to provide Next Generation Sequencing (NGS) sample preparation solutions to Macrogen, Inc., a Korean-based global sequencing company.

May 7, 2012

SEATTLE--(BUSINESS WIRE)--May 7, 2012--Dendreon Corporation (Nasdaq:DNDN) today reported results for the quarter ended March 31, 2012. Net product revenue for the quarter was $82.0 million compared to $27.0 million for the quarter ended March 31...

May 7, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Baird 2012 Growth Stock Conference in Chicago, Illinois on Wednesday, May 9th, at 10:05 a.m. CDT (11:05 a.m...

May 7, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (NASDAQ:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the company will be...

May 7, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--Maxygen, Inc. (Nasdaq:MAXY), a biopharmaceutical company, today announced financial and business results for the quarter ended March 31, 2012. First Quarter 2012 Financial Results Maxygen reported a net loss...

May 7, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the first quarter ended March 31, 2012 and other business updates. Total product revenue was $171.1 million for the...

May 7, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today reported financial results for the first quarter ended March 31, 2012. The net income for the first quarter of 2012 was $31.5 million (or $0.87 per share) compared to a net...

May 7, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that John Higgins, President and Chief Executive Officer will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Thursday, May...

May 7, 2012

NEW YORK--(BUSINESS WIRE)--“OneMedForum NY2012” To Feature Expert Panels, Investor Guides and Disruptive Technologies from Emerging Companies

May 7, 2012

JUPITER, Fla.--(BUSINESS WIRE)--Envoy has been awarded a second grant from The Michael J. Fox Foundation (MJFF) to continue development of compounds that selectively act on the motor circuitry that is compromised in Parkinson's.

May 7, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Clinverse receives $3.8 M to expand its financial technology for clinical trials; will support customer expansion of biopharma’s only cloud-based investigator site payment ecommerce platform.

May 7, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--The Competitive Landscape Seminar Series: Market Access, is a one-day seminar that will be held in New York City on May 17, 2012 addressing healthcare market access drivers and opportunities. The seminar will...

May 7, 2012

BOSTON--(BUSINESS WIRE)--H&Q Healthcare Investors and H&Q Life Sciences Investors announced with profound sadness the death of Lawrence S. Lewin, Chairman of the Board of Trustees of each Fund. Mr. Lewin died on Sunday, April 29th, after...

May 7, 2012

CANDIAC, Quebec--(BUSINESS WIRE)--Cascades Tissue Group, applauds the third annual “STOP! Clean Your Hands Day,” May 7, which is also a good time to note that paper towels are the most hygienic choice when it comes to drying hands.

May 7, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences CEO Kevin Conroy will make the company's presentation at the Baird Growth Stock, JMP Securities Research and Bank of America Merrill Lynch Health Care Conferences during May.

May 7, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. to Report First Quarter 2012 Financial Results on May 9

May 7, 2012

PHILADELPHIA--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced results from a Phase 3 clinical trial evaluating the efficacy, safety and tolerability of once-monthly aripiprazole...

May 7, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Robert Perez, EVP and COO of Cubist, will present on Tuesday May 15th, 2012, at 4:20 p.m. PT, at the Bank of America Merrill Lynch 2012 Health...

May 7, 2012

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--clinicalRSVP recently contributed key insight on subject registries at the 21st Annual Association of Clinical Pharmacology Units (ACPU) Meeting held at the National Institutes of Health (NIH).

May 7, 2012

HORSHAM, Pa.--(BUSINESS WIRE)--Dean Kamen will lead DIA’s meeting with the goal of fostering partnerships that may lead to promising concepts and research into new patient therapies.

May 7, 2012

DANVERS, Mass.--(BUSINESS WIRE)--NeuroLogica Corporation and German based MEYTEC GmbH announced today the development of the world’s first comprehensive mobile stroke ambulance. Stroke-Emergency-Mobile, VIMED® STEMO, combines MEYTEC’s cutting-...

May 7, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Octagon, announced it has been named 2012 Emerging Life Sciences Company of the Year by the Greater Philadelphia Alliance for Capital and Technologies (PACT).

May 7, 2012

GRAND FORKS, N.D.--(BUSINESS WIRE)--NovaDigm today presented Phase 1 data demonstrating that a single dose of NDV-3 with or without alum adjuvant was safe, well-tolerated and induced strong antibody and T-cell immune responses.

May 7, 2012

MALVERN, Pa.--(BUSINESS WIRE)--Promedior announced that data from preclinical studies of Pentraxin-2 (PTX-2) were presented yesterday at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO).

May 7, 2012

FAIRFAX, Va.--(BUSINESS WIRE)--National Institutes of Health (NIH) NIAID awards five-year onsite management contract to SoBran for AAALAC laboratory facilities, including at the Comparative Medicine Branch (CMB).

May 7, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm today announced it can now offer unrestricted sales of its digital PCR to customers interested in pursuing research into the prenatal health and non-invasive prenatal diagnostics fields.

May 7, 2012

WEST ORANGE, N.J.--(BUSINESS WIRE)--ZRG Partners releases Q1 2012 Global Life Sciences hiring index. 4% increase in Q1.

May 7, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it will hold an earnings call on Wednesday, May 9th, at 9 a.m. EDT during which it will...

May 7, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing in oncology, today announced that complete data from the Company’s Phase 1b/2 clinical trial with its proprietary doxorubicin tumor-targeting...

May 7, 2012

NEW YORK--(BUSINESS WIRE)--Retrophin completes Series A investment round.

May 7, 2012

HORSHAM, Pa.--(BUSINESS WIRE)--Galleon Pharmaceuticals Reports Positive Results from Phase I Study of GAL-021 For Treatment of Respiratory Depression

May 7, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion announces upcoming availability of ZETONNA for allergic rhinitis, the only non-aqueous, dry nasal aerosol spray approved with one spray per nostril and once-daily dosing.

May 7, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced new data presented at the 165th Annual Meeting of the American Psychiatric Association (APA) in Philadelphia on PRISTIQ® (desvenlafaxine) Extended Release Tablets 50 mg/day for the...

May 7, 2012

BELLINGHAM, Wash.--(BUSINESS WIRE)--TOKU-E has released Sodium dodecyl sulfate dust free grade. Safer, purer, and faster dissolving.

May 7, 2012

OSAKA, Japan--(BUSINESS WIRE)--Primary and secondary endpoints met in two Phase 3 trials for LATUDA (lurasidone HCl) in adult patients with bipolar I depression. Data were presented at the annual meeting of the APA.

May 7, 2012

PERKASIE, Pa.--(BUSINESS WIRE)--Jeffrey M. Koslosky, vice president, advanced technologies at Secant Medical®, will deliver a presentation, “Biomedical Textiles in Implantable Medical Devices,” at Medical Design & Manufacturing East

May 7, 2012

RICHLAND, Wash.--(BUSINESS WIRE)--GliaSite, worlds only liquid radiation balloon catheter device to treat brain cancers, and Cesium-131 mesh to debut with international medical community. International sales to start soon.

May 7, 2012

LYON, France--(BUSINESS WIRE)--Flamel Technologies announces first quarter 2012 results

May 7, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced the appointment of Thomas M. Moriarty as General Counsel and Corporate Secretary. In this position, he will be responsible for global legal strategy at Celgene and...

May 7, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX expands TripleTOF family with workhorse system for routine analysis

May 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex announced today an interim analysis of data from an ongoing Phase 2 study of VX-809 and KALYDECO™ (ivacaftor).

May 7, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) today announced that it will support an amended stockholder proposal based upon an agreement with Ronald L. Chez, the proponent of the proposal. Mr. Chez submitted an amended...

May 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--data on a tri-antagonist of TLRs 7,8 and 0 in preclinical models of lupus were presented by Idera Pharma at the AAI meeting

May 7, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC: NNVC) announced today that a fundamental patent, on which the nanoviricides® technology is based, is due to be issued in the USA on May 8, 2012.

May 7, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Strategic venture between Smith & Nephew and Essex Woodlands launches new company Bioventus. New company delivers established products to help accelerate bone healing and treat osteoarthritis pain.

May 7, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (“KYTHERA”) today announced the presentation of initial trial results from Study ATX-101-10-16, the first of two pivotal European Phase III clinical trials with ATX-101, a facial...

May 7, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the first quarter ended March 31, 2012. “We just completed our end of Phase 2 meeting with the FDA regarding our...